Mayo Clinic elects Matthew Callstrom CEO to succeed Farrugia
ROCHESTER — November 13, 2026 -- The Mayo Clinic Board of Trustees has elected Matthew R. Callstrom, M.D., Ph.D., to succeed Gianrico Farrugia, M.D., as president and CEO of Mayo Clinic. Farrugia stays in the role through Dec. 31, 2026, which gives the two executives an overlap of about 48 days from the Nov. 13 announcement, by our calculation.
The successor is an internal candidate. Callstrom joined Mayo Clinic in 2002, 24 years before the year of the handover.
Callstrom already sits on two governing boards and runs the AI Program
Callstrom is a member of Mayo Clinic's Board of Governors and of the Board of Trustees that announced his election. He serves as medical director for Mayo Clinic Strategy and the AI Program. He previously was interim chief strategy officer and chair of the Department of Radiology at Mayo Clinic in Rochester.